| Primary |
| Schizophrenia |
40.0% |
| Product Used For Unknown Indication |
22.5% |
| Convulsion |
11.3% |
| Drug Use For Unknown Indication |
7.5% |
| Blood Cholesterol Increased |
5.0% |
| Disease Recurrence |
3.8% |
| Depression |
2.5% |
| Diabetes Mellitus |
2.5% |
| Blood Pressure |
1.3% |
| Psychotic Disorder |
1.3% |
| Schizoaffective Disorder |
1.3% |
| Temporal Lobe Epilepsy |
1.3% |
|
| Drug Toxicity |
15.4% |
| Platelet Count Decreased |
11.5% |
| White Blood Cell Count Increased |
11.5% |
| Ovarian Adenoma |
7.7% |
| Rash |
7.7% |
| Schizophrenia |
7.7% |
| Vomiting |
7.7% |
| Abscess |
3.8% |
| Breast Cancer Metastatic |
3.8% |
| Haemoglobin Decreased |
3.8% |
| Haemoglobin Increased |
3.8% |
| Hypothyroidism |
3.8% |
| Insomnia |
3.8% |
| Metastases To Spine |
3.8% |
| Temporal Lobe Epilepsy |
3.8% |
|
| Secondary |
| Schizophrenia |
32.1% |
| Product Used For Unknown Indication |
24.4% |
| Drug Use For Unknown Indication |
7.1% |
| Convulsion |
6.5% |
| Depression |
6.5% |
| Staphylococcal Infection |
4.8% |
| Schizophrenia, Paranoid Type |
4.2% |
| Hypertension |
3.0% |
| Blood Pressure |
1.8% |
| Hallucination |
1.8% |
| Hepatitis C |
1.2% |
| Hyperinsulinaemia |
1.2% |
| Mental Disorder |
1.2% |
| Anxiety |
0.6% |
| Bacterial Infection |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Blood Pressure Abnormal |
0.6% |
| Lower Respiratory Tract Infection |
0.6% |
| Psychotic Disorder |
0.6% |
| Schizoaffective Disorder |
0.6% |
|
| Hypertension |
12.8% |
| Drug Interaction |
10.6% |
| Platelet Count Decreased |
10.6% |
| White Blood Cell Count Increased |
10.6% |
| Neutropenia |
6.4% |
| General Physical Health Deterioration |
4.3% |
| Haemoglobin Decreased |
4.3% |
| Hyponatraemia |
4.3% |
| Metastases To Spine |
4.3% |
| Rash |
4.3% |
| Rhabdomyolysis |
4.3% |
| Suicide Attempt |
4.3% |
| Tardive Dyskinesia |
4.3% |
| Abscess |
2.1% |
| Condition Aggravated |
2.1% |
| Contralateral Breast Cancer |
2.1% |
| Femur Fracture |
2.1% |
| Galactorrhoea |
2.1% |
| Haemoglobin Increased |
2.1% |
| Hallucination, Auditory |
2.1% |
|
| Concomitant |
| Ill-defined Disorder |
34.5% |
| Product Used For Unknown Indication |
9.2% |
| Schizophrenia |
8.4% |
| Depression |
7.6% |
| Schizophrenia, Paranoid Type |
5.9% |
| Major Depression |
5.0% |
| Affective Disorder |
3.4% |
| Hypertension |
3.4% |
| Drug Use For Unknown Indication |
2.5% |
| Epididymal Infection |
2.5% |
| Insomnia |
2.5% |
| Schizoaffective Disorder |
2.5% |
| Antiplatelet Therapy |
1.7% |
| Cerebrovascular Accident |
1.7% |
| Chronic Hepatitis C |
1.7% |
| Lower Respiratory Tract Infection |
1.7% |
| Mood Swings |
1.7% |
| Osteoporosis |
1.7% |
| Staphylococcal Infection |
1.7% |
| Catatonic Schizophrenia |
0.8% |
|
| Loss Of Consciousness |
15.2% |
| Drug Interaction |
10.9% |
| Rhabdomyolysis |
8.7% |
| International Normalised Ratio Increased |
6.5% |
| Sensation Of Heaviness |
6.5% |
| Tachycardia |
6.5% |
| Arrhythmia |
4.3% |
| Grand Mal Convulsion |
4.3% |
| Iron Deficiency Anaemia |
4.3% |
| Orchitis |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Sopor |
4.3% |
| Vomiting |
4.3% |
| Confusional State |
2.2% |
| Conjunctival Disorder |
2.2% |
| Death |
2.2% |
| Diabetes Mellitus Insulin-dependent |
2.2% |
| Dyspnoea |
2.2% |
| Electrocardiogram Qt Prolonged |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
|
